{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as dominantly inherited Parkinson's disease caused by mutations in the LRRK2 gene."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The assays used (inclusion body formation and cell death) effectively model the disease pathogenesis by showing the toxic effects of mutant dardarin.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Manipulating activity by replacing the kinase domain with a Fkinase-dead_ version blocks inclusion body formation and strongly delays cell death.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of kinase-dead versions as controls, indicating the presence of basic controls.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The kinase-dead versions of the same constructs produced delayed cell death compared to the kinase active forms.",
          "judgment": "Yes",
          "reasoning": "The use of kinase-dead versions as controls for the pathogenic variants indicates the presence of variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "G2019S produced a small increase in autophosphorylation activity ( P < 0.05).",
          "judgment": "Yes",
          "reasoning": "The paper provides statistical analysis showing a significant increase in autophosphorylation activity for G2019S.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "G2019S produced a small increase in autophosphorylation activity ( P < 0.05).",
          "judgment": "Yes",
          "reasoning": "The statistical significance (P < 0.05) suggests a moderate increase in activity, aligning with a moderate strength of evidence.",
          "next_step_or_outcome": "Assign PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The G2019S variant in LRRK2 shows a moderate increase in autophosphorylation activity, supporting its pathogenic role in Parkinson's disease with moderate strength evidence (PS3_moderate)."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as dominantly inherited Parkinson's disease caused by mutations in the LRRK2 gene."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The assays used (inclusion body formation and cell death) effectively model the disease pathogenesis by showing the toxic effects of mutant dardarin.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Manipulating activity by replacing the kinase domain with a Fkinase-dead_ version blocks inclusion body formation and strongly delays cell death.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of kinase-dead versions as controls, indicating the presence of basic controls.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The kinase-dead versions of the same constructs produced delayed cell death compared to the kinase active forms.",
          "judgment": "Yes",
          "reasoning": "The use of kinase-dead versions as controls for the pathogenic variants indicates the presence of variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "R1441C showed no increase in autophosphorylation activity.",
          "judgment": "No",
          "reasoning": "The paper does not provide statistical evidence of increased activity for R1441C, suggesting a lack of direct functional evidence for pathogenicity.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "N/A"
      },
      "overall_conclusion": "The R1441C variant in LRRK2 does not show increased autophosphorylation activity, and thus, functional evidence for pathogenicity is not applicable (N/A)."
    }
  ]
}